These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study. Chen Z; Zheng W; Wu Q; Chen X; Peng C; Tian Y; Sun R; Dong J; Wang M; Zhou X; Zhao Z; Zhong G; Yan X; Liu N; Hao F; Zhao S; Zhuang T; Yang J; Azman AS; Yu H BMC Med; 2022 Apr; 20(1):130. PubMed ID: 35369871 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022. Thompson MG; Natarajan K; Irving SA; Rowley EA; Griggs EP; Gaglani M; Klein NP; Grannis SJ; DeSilva MB; Stenehjem E; Reese SE; Dickerson M; Naleway AL; Han J; Konatham D; McEvoy C; Rao S; Dixon BE; Dascomb K; Lewis N; Levy ME; Patel P; Liao IC; Kharbanda AB; Barron MA; Fadel WF; Grisel N; Goddard K; Yang DH; Wondimu MH; Murthy K; Valvi NR; Arndorfer J; Fireman B; Dunne MM; Embi P; Azziz-Baumgartner E; Zerbo O; Bozio CH; Reynolds S; Ferdinands J; Williams J; Link-Gelles R; Schrag SJ; Verani JR; Ball S; Ong TC MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):139-145. PubMed ID: 35085224 [TBL] [Abstract][Full Text] [Related]
5. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021. León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222 [TBL] [Abstract][Full Text] [Related]
6. Who should be prioritized for COVID-19 vaccination in China? A descriptive study. Yang J; Zheng W; Shi H; Yan X; Dong K; You Q; Zhong G; Gong H; Chen Z; Jit M; Viboud C; Ajelli M; Yu H BMC Med; 2021 Feb; 19(1):45. PubMed ID: 33563270 [TBL] [Abstract][Full Text] [Related]
7. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years - United States, August 31-October 23, 2022. Hause AM; Marquez P; Zhang B; Myers TR; Gee J; Su JR; Blanc PG; Thomas A; Thompson D; Shimabukuro TT; Shay DK MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(44):1401-1406. PubMed ID: 36327162 [TBL] [Abstract][Full Text] [Related]
8. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)]. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607 [TBL] [Abstract][Full Text] [Related]
9. Inequities in COVID-19 vaccine and booster coverage across Massachusetts ZIP codes after the emergence of Omicron: A population-based cross-sectional study. Bor J; Assoumou SA; Lane K; Diaz Y; Ojikutu BO; Raifman J; Levy JI PLoS Med; 2023 Jan; 20(1):e1004167. PubMed ID: 36719864 [TBL] [Abstract][Full Text] [Related]
10. The impact of national income and vaccine hesitancy on country-level COVID-19 vaccine uptake. Moradpour J; Shajarizadeh A; Carter J; Chit A; Grootendorst P PLoS One; 2023; 18(11):e0293184. PubMed ID: 37917650 [TBL] [Abstract][Full Text] [Related]
11. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023. Hause AM; Marquez P; Zhang B; Su JR; Myers TR; Gee J; Panchanathan SS; Thompson D; Shimabukuro TT; Shay DK MMWR Morb Mortal Wkly Rep; 2023 Jan; 72(2):39-43. PubMed ID: 36634021 [TBL] [Abstract][Full Text] [Related]
12. Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study. Wang W; Wu Q; Yang J; Dong K; Chen X; Bai X; Chen X; Chen Z; Viboud C; Ajelli M; Yu H BMJ; 2020 Dec; 371():m4704. PubMed ID: 33323388 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022. Natarajan K; Prasad N; Dascomb K; Irving SA; Yang DH; Gaglani M; Klein NP; DeSilva MB; Ong TC; Grannis SJ; Stenehjem E; Link-Gelles R; Rowley EA; Naleway AL; Han J; Raiyani C; Benitez GV; Rao S; Lewis N; Fadel WF; Grisel N; Griggs EP; Dunne MM; Stockwell MS; Mamawala M; McEvoy C; Barron MA; Goddard K; Valvi NR; Arndorfer J; Patel P; Mitchell PK; Smith M; Kharbanda AB; Fireman B; Embi PJ; Dickerson M; Davis JM; Zerbo O; Dalton AF; Wondimu MH; Azziz-Baumgartner E; Bozio CH; Reynolds S; Ferdinands J; Williams J; Schrag SJ; Verani JR; Ball S; Thompson MG; Dixon BE MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(13):495-502. PubMed ID: 35358170 [TBL] [Abstract][Full Text] [Related]
14. Covid-19 pandemic and equity of global human papillomavirus vaccination: descriptive study of World Health Organization-Unicef vaccination coverage estimates. Casey RM; Akaba H; Hyde TB; Bloem P BMJ Med; 2024; 3(1):e000726. PubMed ID: 38293682 [TBL] [Abstract][Full Text] [Related]
15. Assessing New York City's COVID-19 Vaccine Rollout Strategy: A Case for Risk-Informed Distribution. Schwalbe N; Nunes MC; Cutland C; Wahl B; Reidpath D J Urban Health; 2024 Oct; 101(5):923-933. PubMed ID: 38578336 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022. Britton A; Embi PJ; Levy ME; Gaglani M; DeSilva MB; Dixon BE; Dascomb K; Patel P; Schrader KE; Klein NP; Ong TC; Natarajan K; Hartmann E; Kharbanda AB; Irving SA; Dickerson M; Dunne MM; Raiyani C; Grannis SJ; Stenehjem E; Zerbo O; Rao S; Han J; Sloan-Aagard C; Griggs EP; Weber ZA; Murthy K; Fadel WF; Grisel N; McEvoy C; Lewis N; Barron MA; Nanez J; Reese SE; Mamawala M; Valvi NR; Arndorfer J; Goddard K; Yang DH; Fireman B; Ball SW; Link-Gelles R; Naleway AL; Tenforde MW MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(42):1335-1342. PubMed ID: 36264840 [TBL] [Abstract][Full Text] [Related]
17. Disparities in access to COVID-19 vaccine in Verona, Italy: a cohort study using local health immunization data. Benoni R; Sartorello A; Moretti F; Marchiori F; Accordini L; Postiglione C; Coffele V; Tardivo S Front Public Health; 2023; 11():1167414. PubMed ID: 37397767 [TBL] [Abstract][Full Text] [Related]
18. A flexible age-dependent, spatially-stratified predictive model for the spread of COVID-19, accounting for multiple viral variants and vaccines. Schneider KA; Tsoungui Obama HCJ; Adil Mahmoud Yousif N PLoS One; 2023; 18(1):e0277505. PubMed ID: 36662784 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of a COVID-19 Vaccine Campaign and SARS-CoV-2 Infection and Mortality Among Adults Aged 60 Years And Older in a Middle-Income Country. Macchia A; Ferrante D; Angeleri P; Biscayart C; Mariani J; Esteban S; Tablado MR; de Quirós FGB JAMA Netw Open; 2021 Oct; 4(10):e2130800. PubMed ID: 34714342 [TBL] [Abstract][Full Text] [Related]